People: Bioline RX Ltd (BLRX.W)

BLRX.W on CBOE When Trading NASDAQ Global Select Market

1.62USD
18 Jun 2013
Price Change (% chg)

$-0.11 (-6.36%)
Prev Close
$1.73
Open
$1.61
Day's High
$1.62
Day's Low
$1.61
Volume
573
Avg. Vol
61
52-wk High
$4.27
52-wk Low
$1.58

Search Stocks

Serlin, Philip 

Brief Biography

Mr. Philip A. Serlin serves as Chief Financial Officer and Chief Operating Officer at BioLine Rx Ltd since May, 2009. Prior to joining BioLineRx, Mr. Serlin was Chief Financial Officer and Chief Operating Officer of Kayote Networks Ltd. Mr. Serlin also served as Chief Financial Officer of Tescom Software Systems Testing Ltd. His background also includes senior positions at Chiaro Networks Ltd. and at Deloitte, where he was head of the SEC and U.S. accounting department at the National Office in Tel Aviv, as well as seven years at the SEC at its Washington, D.C., headquarters. Mr. Serlin is a Certified Public Accountant and holds a Masters degree in Economics and Public Policy from The George Washington University and a BSC degree in Accounting from the Yeshiva University.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Search Stocks